BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
1-Year Return
65.92%
This Quarter Return
+28.68%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$131M
AUM Growth
+$4.53M
(+3.6%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-8.62%
Top 10 Holdings %
Top 10 Hldgs %
64.4%
Holding
34
New
7
Increased
2
Reduced
15
Closed
9
Top Buys
| 1 |
Protalix BioTherapeutics
PLX
|
+$8.97M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
+$8.24M |
| 3 |
INZY
Inozyme Pharma
INZY
|
+$3.53M |
| 4 |
Intellia Therapeutics
NTLA
|
+$3.49M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
+$2.82M |
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
+$11.5M |
| 2 |
OrthoPediatrics
KIDS
|
+$7.88M |
| 3 |
AnaptysBio
ANAB
|
+$4.88M |
| 4 |
Assembly Biosciences
ASMB
|
+$3.29M |
| 5 |
Regenxbio
RGNX
|
+$3.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AnaptysBio
ANAB
$655M
| – | – |
-330,549
| Closed | -$4.88M |
|
|
27
Assembly Biosciences
ASMB
$168M
| – | – |
-16,667
| Closed | -$3.29M |
|
|
28
OrthoPediatrics
KIDS
$493M
| – | – |
-171,607
| Closed | -$7.88M |
|
|
29
Regenxbio
RGNX
$465M
| – | – |
-116,405
| Closed | -$3.2M |
|
|
CALT
30
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| – | – |
-11,034
| Closed | -$265K |
|
|
KDNY
31
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-27,180
| Closed | -$330K |
|
|
TCDA
32
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
-188,182
| Closed | -$1.71M |
|
|
AIMT
33
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| – | – |
-332,546
| Closed | -$11.5M |
|
|
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-39,189
| Closed | -$703K |
|